Published on
May 29, 2026
- 21:23 GMT
Kuva and Lisata Therapeutics Amend Merger Agreement
HOUSTON, TX, UNITED STATES, May 29, 2026 /EINPresswire.com/ -- On May 29, 2026, Kuva Labs, Inc. (“Kuva” or “Parent”) and Lisata Therapeutics, Inc. (“Lisata”) (Nasdaq: LSTA), together with Kuva’s wholly owned subsidiary Kuva Acquisition Corp. (“Kuva …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
